
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-42 of 42.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2011	Shortened dynamic (18)F-FDG PET	Disselhorst, J.A.; Vriens, D.; de Geus-Oei, L.F.; Oyen, W.J.G.; Visser, E.P.
2011	De rol van 99m-Tc-MAG3 renografie in de postnatale evaluatie van kinderen met verdenking op een congenitale afwijking van de tractus urogenitalis.	Koster-Kamphuis, L.; Geus-Oei, L.F. de; Schreuder, M.F.; Feitz, W.F.J.
2011	The role of FDG-PET in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.	Vriens, D.; Wilt, J.H.W. de; Wilt, G.J. van der; Netea-Maier, R.T.; Oyen, W.J.G.; Geus-Oei, L.F. de
2011	Clinical applications of positron emission tomography in sarcoma management	Quak, E.; Luijtgaarden, A.C.M. van de; de Geus-Oei, L.F.; van der Graaf, W.T.; Oyen, W.J.G.
2011	Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET	Vriens, D.; de Geus-Oei, L.F.; Heerschap, A.; van Laarhoven, H.W.; Oyen, W.J.G.
2011	F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis	Rooy, J.W. de; Hambrock, T.; Vriens, D.; Flucke, U.E.; Geest, I.C.M. van der; Luijtgaarden, A.C.M. van de; Schreuder, B.; Geus-Oei, L.F. de
2011	EUS-FNA for the detection of left adrenal metastasis in patients with lung cancer	Schuurbiers, O.C.J.; Tournoy, K.G.; Schoppers, H.J.; Dijkman, B.; Timmers, H.J.L.M.; Geus-Oei, L.F. de; Grefte, J.M.M.; Rabe, K.F.; Dekhuijzen, P.N.R.; Heijden, H.F. van der; Annema, J.T.
2011	Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity	Geus-Oei, L.F. de; Mavinkurve-Groothuis, A.M.C.; Bellersen, L.; Gotthardt, M.; Oyen, W.J.G.; Kapusta, L.; Laarhoven, H.W.M. van
2010	Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma.	Luijtgaarden, A.C.M. van de; Flucke, U.E.; Graaf, W.T.A. van der; Rooy, J.W.J. de; Bonenkamp, J.J.; Geus-Oei, L.F. de
2010	Nodular fasciitis on F18-DG PET	Gotthardt, M.; Arens, A.I.J.; Heijden, H.F.M. van der; Veth, R.P.H.; Geus-Oei, L.F. de; Oyen, W.J.G.
2010	Benign uterine uptake of FDG: a case report and review of literature.	Vriens, D.; Geus-Oei, L.F. de; Flucke, U.E.; Kogel, A.J. van der; Oyen, W.J.G.; Vierhout, M.E.; Meer, J.W.M. van der
2010	Nodular fasciitis on F-18 FDG PET.	Gotthardt, M.; Arens, A.I.J.; Heijden, E. van der; Geus-Oei, L.F. de; Oyen, W.J.G.
2010	Methodological considerations in quantification of oncological FDG PET studies.	Vriens, D.; Visser, E.P.; Geus-Oei, L.F. de; Oyen, W.J.G.
2010	Comparison of two region of interest definition methods for metabolic response evaluation with [18F]FDG-PET.	Vriens, D.; Geus-Oei, L.F. de; Laarhoven, H.W.M. van; Heijden, H.F. van der; Krabbe, P.F.M.; Visser, E.P.; Oyen, W.J.G.
2010	The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.	Dijkman, B.; Schuurbiers, O.C.J.; Vriens, D.; Looijen-Salamon, M.G.; Bussink, J.; Timmer-Bonte, J.N.H.; Snoeren, M.M.; Oyen, W.J.G.; Heijden, H.F. van der; Geus-Oei, L.F. de
2009	Postural headache in marfan syndrome associated with spinal cysts and liquor hypotension.	Voermans, N.C.; Dijk, K.G.; Bos, M.M.; Geus-Oei, L.F. de; Verrips, A.; Lindert, E.J. van
2009	Tailoring therapy in colorectal cancer by PET-CT.	Vriens, D.; Geus-Oei, L.F. de; Graaf, W.T.A. van der; Oyen, W.J.G.
2009	Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer : a systematic review	Geus-Oei, L.F. de; Vriens, D.; Laarhoven, H.W.M. van; Graaf, W.T.A. van der; Oyen, W.J.G.
2009	Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.	Vriens, D.; Geus-Oei, L.F. de; Laarhoven, H.W.M. van; Timmer-Bonte, J.N.H.; Krabbe, P.F.M.; Visser, E.P.; Oyen, W.J.G.
2009	Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.	Vriens, D.; Laarhoven, H.W.M. van; Asten, J.J.A. van; Krabbe, P.F.M.; Visser, E.P.; Heerschap, A.; Punt, C.J.A.; Geus-Oei, L.F. de; Oyen, W.J.G.
2009	A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment.	Vriens, D.; Geus-Oei, L.F. de; Oyen, W.J.G.; Visser, E.P.
2008	Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.	Luijtgaarden, A.C.M. van de; Rooy, J.W. de; Geus-Oei, L.F. de; Graaf, W.T. van der; Oyen, W.J.G.
2008	Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.	Geus-Oei, L.F. de; Laarhoven, H.W.M. van; Visser, E.P.; Hermsen, R.; Hoorn, B.A. van; Kamm, Y.J.L.; Krabbe, P.F.M.; Corstens, F.H.M.; Punt, C.J.A.; Oyen, W.J.G.
2008	Predictive and prognostic value of FDG-PET.	Geus-Oei, L.F. de; Oyen, W.J.G.
2008	Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.	Visser, E.P.; Philippens, M.E.P.; Kienhorst, L.; Kaanders, J.H.A.M.; Corstens, F.H.M.; Geus-Oei, L.F. de; Oyen, W.J.G.
2007	Characterization of malignancy with FDG-PET	Geus-Oei, L.F. de
2007	Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.	Geus-Oei, L.F. de; Heijden, H.F.M. van der; Corstens, F.H.M.; Oyen, W.J.G.
2007	A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.	Bleeker-Rovers, C.P.; Vos, F.J.; Mudde, A.H.; Dofferhoff, A.S.M.; Geus-Oei, L.F. de; Rijnders, A.J.; Krabbe, P.F.M.; Corstens, F.H.M.; Meer, J.W.M. van der; Oyen, W.J.G.
2007	Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.	Geus-Oei, L.F. de; Heijden, H.F.M. van der; Visser, E.P.; Hermsen, R.; Hoorn, B.A. van; Timmer-Bonte, J.N.H.; Willemsen, A.T.M.; Pruim, J.; Corstens, F.H.M.; Krabbe, P.F.M.; Oyen, W.J.G.
2007	Biological correlates of FDG uptake in non-small cell lung cancer.	Geus-Oei, L.F. de; Krieken, J.H.J.M. van; Aliredjo, R.P.; Krabbe, P.F.M.; Frielink, C.; Verhagen, A.F.T.M.; Boerman, O.C.; Oyen, W.J.G.
2006	Imatinib maakt maagsparende tumorresectie mogelijk.	Wobbes, Th.; Hoesel, Q.G.C.M. van; Geus-Oei, L.F. de; Boer, S.Y. de
2006	Gadopentetate Dimeglumine and FDG Uptake in Liver Metastases.	Miles, K.; Keith, C.; Laarhoven, H.W.M. van; Geus-Oei, L.F. de; Wiering, B.; Lok, J.; Rijpkema, M.J.P.; Kaanders, J.H.A.M.; Krabbe, P.F.M.; Ruers, T.J.M.; Punt, C.J.A.; Kogel, A.J. van der; Oyen, W.J.G.; Heerschap, A.
2006	Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.	Geus-Oei, L.F. de; Kaanders, J.H.A.M.; Pop, L.A.M.; Corstens, F.H.M.; Oyen, W.J.G.
2006	Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.	Geus-Oei, L.F. de; Visser, E.P.; Krabbe, P.F.M.; Hoorn, B.A. van; Koenders, E.B.; Willemsen, A.T.M.; Pruim, J.; Corstens, F.H.M.; Oyen, W.J.G.
2006	FDG-PET in colorectal cancer.	Geus-Oei, L.F. de; Ruers, T.J.M.; Punt, C.J.A.; Leer, J.W.H.; Corstens, F.H.M.; Oyen, W.J.G.
2006	FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.	Geus-Oei, L.F. de; Wiering, B.; Krabbe, P.F.M.; Ruers, T.J.M.; Punt, C.J.A.; Oyen, W.J.G.
2006	Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody.	Eerd-Vismale, J.E.M. van; Geus-Oei, L.F. de; Oyen, W.J.G.; Corstens, F.H.M.; Boerman, O.C.
2006	18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.	Geus-Oei, L.F. de; Pieters, G.F.F.M.; Bonenkamp, J.J.; Mudde, A.H.; Bleeker-Rovers, C.P.; Corstens, F.H.M.; Oyen, W.J.G.
2005	Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.	Peeters, C.F.J.M.; Geus-Oei, L.F. de; Westphal, J.R.; Waal, R.M.W. de; Ruiter, D.J.; Wobbes, Th.; Oyen, W.J.G.; Ruers, T.J.M.
2005	Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.	Laarhoven, H.W.M. van; Geus-Oei, L.F. de; Wiering, B.; Lok, J.; Rijpkema, M.J.P.; Kaanders, J.H.A.M.; Krabbe, P.F.M.; Ruers, T.J.M.; Punt, C.J.A.; Kogel, A.J. van der; Oyen, W.J.G.; Heerschap, A.
2004	F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.	Bleeker-Rovers, C.P.; Ven, A.J.A.M. van der; Zomer, B.; Geus-Oei, L.F. de; Smits, P.; Corstens, F.H.M.; Koopmans, P.P.; Oyen, W.J.G.
2004	Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals.	Geus-Oei, L.F. de; Eerd-Vismale, J.E.M. van; Molthoff, C.F.M.; Corstens, F.H.M.; Oyen, W.J.G.; Boerman, O.C.